Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 9 (E) Erythromycin Oxime. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108948114B enables high-purity 9-(E)-erythromycin oxime via novel biphasic impurity removal, ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.